Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome

European Journal of Endocrinology

Volumn 158, Issue 4, 2008, Pages 511-516

  Barber, Thomas M ^a   Casanueva, Felipe F ^b   Karpe, Fredrik ^a   Lage, Mary ^b   Franks, Stephen ^c   McCarthy, Mark I ^a   Wass, John A H ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUCOSE; INSULIN; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GEOMETRY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL; UNITED KINGDOM; BLOOD; DOWN REGULATION; DRUG EFFECT; GLUCOSE TOLERANCE TEST; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY;

ADMINISTRATION, ORAL; ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; DOWN-REGULATION; FASTING; FEMALE; GHRELIN; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME;

EID: 41749094970     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0683     Document Type: Article

References (21)

1. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004 19 41-47.
2. Barber TM, McCarthy MI, Wass JA & Franks S. Obesity and polycystic ovary syndrome. Clinical Endocrinology 2006 65 137-145.
3. Barber TM, Wass JA, McCarthy MI & Franks S. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clinical Endocrinology 2007 66 513-517.
4. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 656-660.
5. Tschop M, Smiley DL & Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000 407 908-913.
6. Cummings DE. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiology and Behavior 2006 89 71-84.
7. Tschop M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, Landgraf R & Folwaczny C. Post-prandial decrease of circulating human ghrelin levels. Journal of Endocrinological Investigation 2001 24 RC19-RC21.
8. Wren AM, Seal LJ, Cohen MA. Brynes AE, Frost GS. Murphy KG, Dhillo WS, Ghatei MA & Bloom SR. Ghrelin enhances appetite and increases food intake in humans. Journal of Clinical Endocrinology and Metabolism 2001 86 5992.
9. Scholl C, Horn R, Schill T, Schlosser HW, Muller MJ & Brabant G. Circulating ghrelin levels in patients with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2002 87 4607-4610.
10. Panidis D, Farmakiotis D, Koliakos G, Rousso D, Kourtis A, Katsikis I, Asteriadis C, Karayannis V & Diamanti-Kandarakis E. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls. Human Reproduction 2005 20 2127-2132.
11. Pagotto U, Gambineri A, Vicennati V, Heiman ML, Tschop M & Pasquali R. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. Journal of Clinical Endocrinology and Metabolism 2002 87 5625-5629.
12. Wasko R, Komarowska H, Warenik-Szymankiewicz A & Sowinski J. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome. Hormone and Metabolic Research 2004 36 170-173.
13. Gambineri A, Pagotto U, Tschop M, Vicennati V, Manicardi E, Carcello A, Cacciari M, De Iasio R & Pasquali R. Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome. Journal of Endocrinological Investigation 2003 26 629-634.
14. Orio F Jr, Lucidi F, Palomba S, Tauchmanova L, Cascella T, Russo T, Zullo F, Colao A. Lombardi G & De Feo P. Circulating ghrelin concentrations in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 942-945.
15. Moran LJ, Noakes M, Clifton PM. Wittert GA, Tomlinson L, Galletly C, Luscombe ND & Norman RJ. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. Journal of Clinical Endocrinology and Metabolism 2004 89 3337-1344.
16. Adams J, Pelson DW & Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. British Medical journal (Clinical Research Ed.) 1986 293 355-359.
17. Ritchie JD, Miller CK & Smiciklas-Wright H. Tanita foot-to-foot bioelectrical impedance analysis system validated in older adults. Journal of the American Dietetic Association 2005 105 1617-1619.
18. Mari A, Pacini G, Brazzale AR & Ahren B. Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test. Diabetologia 2005 48 748-751.
19. Barkan AL, Dimaraki EV, Jessup SK, Symons KV, Ermotenko M & Jaffe CA. Ghretin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. Journal of Clinical Endocrinology and Metabolism 2003 88 2180-2184.
20. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K & Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. Journal of Clinical Endocrinology and Metabolism 2002 87 240-244.
21. Katsuki A, Urakawa H. Gabazza EC, Murashima S, Nakatani K, Togashi K, Yano Y, Adachi Y & Sumida Y. Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus. European Journal of Endocrinology 2004 151 573-577.